References
- Simon SM, Schindler M. Cell biological mechanism of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994; 91: 3497–3504.
- Gao YT, Mc Laughlin JK, Blot WJ, Ji BT, Dai Q, FraumeniJr JF. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994; 86: 855–858.
- Dreosti IE, Wargavich MJ, Yang CS. Inhibition of car-cinogenesis by tea: the evidence from experimental studies. Crit Rev Food Sci Nutr 1997; 37: 761–770.
- Kato I, Tominaga S, Matsuura A, Yoshii Y, Shirai M, Kobayashi S. A comparative case-control study of colorectal cancer and adenoma. Jpn J Cancer Res 1990; 81: 1101–1108.
- Huang MT, Ho CT, Wang ZY, et al. Inhibitory effects of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992; 13: 947–954.
- Katiyar SK, Mukhtar H. Tea in chemoprevention of can-cer, epidemiologic and experimental studies. Int J Oncol 1996; 8: 221–238.
- Narasiwa T, Fukaura Y. A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res 1993; 84: 1007-1009.
- Zloch Z. The role of dietary plant polyphenols in health maintenance. Cas Lek Cesk 1996; 135: 84–88.
- Weisburger JH. Tea and health: the underlying mecha-nisms. Proc Soc Exp Biol Med 1999; 220: 271–275.
- Buschman JL. Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998; 31: 151–159.
- Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk of stomach cancer - a popula-tion-based case-control study in Shanghai, China. Cancer Causes Control 1995; 6: 532-538.
- Yasuyuki S, Tomomoi S, Takashi S. Efficacies of tea components on doxorubicin induced anticancer activity and reversal of multidrug resistance. Toxicol Lett 2000; 114: 155–162.
- Gerd S, Manfred V. Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistance cell lines. Anticancer Drugs 1997; 8: 265–268.
- Sugiyama K, Ueda H. Protective effects of tea on toxic side platinum effects by anticancer drug, cisplatin in mice. Proc International Symposium on Tea Science 1991; 352: 26–29.
- Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993; 85: 1038–1049.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxici-ty assays. J Immunol Meth 1983; 65: 55–63.
- Rajesh K, Lawrence DM. Multidrug resistance (MDR) in cancer mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinet-ics of anticancer drugs. Eur J Pharm Sci 2000; 11: 265–283.
- Meister A. Glutathione, ascorbate, and cellular protec-tion. Cancer Res 1994; 54: 1969S-1975S.
- Hao XY, Widersten M, Ridderstorm M, Hellamn U, Mamervik B. Co-variation of glutathione transferase expres-sion and cytostatic drug resistance in HeLa cells: Establishment of class Mu glutasthione transferase M3-3 as the domination isoenzyme. Biochem J 1994; 297: 59–67.
- Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K. Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice. Int J Cancer 1992; 50: 760–766.
- Kamath N, Grabowski D, Ford J, Kerrigan D, Pommier Y, Ganapathi R. Overexpression of P-glycoprotein and alter-ations in topoisomerase II in p388 mouse leukaemia cells selected in vivo for resistance to metoxantrone. Biochem Pharmacol 1992; 44: 937–945.
- Borst P, Kool PM, Evers R. Do cMOAT (MRP2), other MRP homologues and LRP play a role in MDR. Cancer Biol 1997; 8: 205–213.
- Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein increases resistance to natural product drugs. Cancer Res 1994; 54: 357–361.
- Chambers T, Mcavoy E, Jacobs J, Eilon G. PKC phos-phorylates P-glycoprotein in MDR human KB carcinoma cells. J Biol Chem 265: 7679–86, 1990.
- Taniguchi H, Pyerin W. Glutathione 5-transferase in an in vitro substrate of Ca±±-phospholipid-dependent protein kinase (protein kinase C). Biochem Biophys Res Commun 1989; 162: 903–907.
- Sahyoun N, Wolf M, Besterman J, et al. Protein kinase C phophorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 1986; 83: 1603-1607.